Validation of TDP-43 Splicing Repression as a Therapeutic Strategy for ALS and FTD
Conference abstract presented at ASGCT 2024 on validating TDP-43 splicing repression as a therapeutic strategy for ALS and FTD.
Conference abstract presented at ASGCT 2024 on validating TDP-43 splicing repression as a therapeutic strategy for ALS and FTD.
Meta-analysis of TCM syndrome elements in amyotrophic lateral sclerosis.
Systematic review and meta-analysis evaluating the safety and efficacy of edaravone in ALS patients.
Data mining analysis of prescription patterns in traditional Chinese medicine for treating ALS-related atrophy disease in classical texts.